English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

To evaluate the frequency and predictive factors of discordant immune response, we performed a prospective cohort study of 288 antiretroviral-naive human immunodeficiency virus (HIV)-infected patients who initiated highly active antiretroviral therapy (HAART) and maintained complete virus suppression for &gt; or =24 months. The median CD4+ cell count was 186x10(6) cells/L, and the median HIV RNA level was 5 log(10) copies/mL. After 24 months of therapy, 42 (16.5%) of 255 patients had a median CD4+ cell count increase of &lt;100x10(6) cells/L. By logistic regression analysis, previous injection drug use was associated with a CD4+ cell count increase of &lt;100x10(6) cells/L (risk ratio [RR], 2.326; 95% confidence interval [CI], 1.077-5.023; P=.032); inclusion of a protease inhibitor (PI) in the HAART regimen reduced the risk of poor immunologic recovery (RR, 0.160; 95% CI, 0.061-0.417; P&lt;.001). Failure of the CD4+ cell count to increase was relatively common among antiretroviral-naive patients in the year after the initiation of HAART and the achievement of complete virus suppression. PI-containing regimens provided better immunologic response.

clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)

Long‐Term Outcomes among Antiretroviral‐Naive Human Immunodeficiency Virus–Infected Patients with Small Increases in CD4<sup>+</sup>Cell Counts after Successful Virologic Suppression

Long‐Term Outcomes among Antiretroviral‐Naive Human Immunodeficiency Virus–Infected Patients with Small Increases in CD4+Cell Counts after Successful Virologic Suppression

Long‐Term Outcomes among Antiretroviral‐Naive Human Immunodeficiency Virus–Infected Patients with Small Increases in CD4⁺Cell Counts after Successful Virologic Suppression